Shukra Pharmaceuticals

Price chart

Previous close

₹81.58

Open

₹81.90

Day high

₹84.50

Day low

₹81.06

Listed on NSE since 14 August 2026.

Market value

₹3,610.10 Cr

P/E (trailing)

104.59

EPS (trailing)

₹0.78

Price to book

38.96

Dividend yield

0.01%

Debt to equity

0.06

Profit margin

45.4%

Beta

0.55

Volume today

26.98 L

Average volume

62.26 L

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Source: Yahoo Finance, from annual reports. Consolidated where reported. EPS before FY24 is not shown: the share count changed (a bonus, split or merger), so earlier figures would not compare.

Source: Shukra Pharmaceuticals’s results filed with NSE, consolidated (the whole group). Net profit is the share of Shukra Pharmaceuticals’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Source: Shukra Pharmaceuticals’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

SHUKRA MEDTECH LIMITED engages in the manufacturing, marketing, and export of pharmaceutical formulations in India and internationally. The company offers various products, such as antibiotics, anti biotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products. It provides its products in ampoules, capsules, vials, and tablet forms. In addition, the company provides laboratory services; and surgical robots, diabetes technologies, cardiac sciences, advanced surgical and diagnostic solutions, imaging and critical care, medical simulations, wound care, boron neutron capture therapy, and virtual autopsy and forensic sciences. Further, it is involved in the supplying, selling, and distributing medical consumables; offers wound care products, medical, surgical, healthcare devices, materials, consumables, and allied solutions, as well as diabetes-related medical technologies solutions; and provision of virtual autopsy services and solutions. Additionally, the company offers expendable and non-expendable medical products, medical devices, emergency healthcare systems, combat medical support systems, first aid kits, trauma care kits; and artificial intelligence (AI), machine learning, deep learning, data analytics, predictive analytics, computer vision, natural language processing, generative AI, robotics, automation, digital platforms, hardware, cloud-based systems, decision support systems, and other technology solutions. The company was formerly known as Shukra Pharmaceuticals Limited and changed its name to SHUKRA MEDTECH LIMITED in October 2026. SHUKRA MEDTECH LIMITED was incorporated in 1993 and is headquartered in Ahmedabad, India.

Industry

Drug Manufacturers - Specialty & Generic

Based in

Ahmedabad

Company website · Profile: Yahoo Finance

No headlines name Shukra Pharmaceuticals in the last day or two.

• Dividend - Re 0.01 Per Share

  Dividend · ex-date 21 September 2026

Source: NSE. Latest first.